Next Article in Journal
Nasal Nitric Oxide in Chronic Rhinosinusitis with or without Nasal Polyps: A Systematic Review with Meta-Analysis
Next Article in Special Issue
Targeting the Host for New Therapeutic Perspectives in Hepatitis D
Previous Article in Journal
Alternative Applications of Trans-Oral Robotic Surgery (TORS): A Systematic Review
Previous Article in Special Issue
Impact of Sustained Virological Response for Gastroesophageal Varices in Hepatitis-C-Virus-Related Liver Cirrhosis
Open AccessReview

Isolated Anti-HBc: Significance and Management

1
Infectious Diseases Department, Dijon University Hospital, 21079 Dijon, France
2
INSERM CIC 1432, Module Plurithématique, University of Burgundy, 21079 Dijon, France
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2020, 9(1), 202; https://doi.org/10.3390/jcm9010202
Received: 9 December 2019 / Revised: 6 January 2020 / Accepted: 7 January 2020 / Published: 11 January 2020
Hepatitis B virus (HBV) infection is prevalent worldwide and is associated with dramatic levels of morbidity and mortality. Isolated anti-HBc (IAHBc) is a particular serological pattern that is commonly found in immunocompromised patients. There is ongoing debate regarding the management of patients with IAHBc. Herein, we summarize the current guidelines and the newest evidence. The frequency of IAHBc is variable, with a higher prevalence in some populations, such as persons living with HIV and others immunocompromised patients. The risk of HBV reactivation depends on host factors (including immunosuppression) and viral factors. It is now well established that immunocompromised patients can be classified into three groups for risk according to the type of immunosuppression and/or treatment. In patients at high risk, HBV therapy has to be considered systematically. In patients at moderate risk, the decision is based on the level of HBV DNA (preemptive treatment or monitoring and vaccination). In patients with low risk, HBV vaccination is another possible approach, although further studies are needed to assess the type of preemptive strategy. View Full-Text
Keywords: viral hepatitis; isolated anti-HBc antibodies; immunosuppression; hepatitis B infection; HBV reactivation; management viral hepatitis; isolated anti-HBc antibodies; immunosuppression; hepatitis B infection; HBV reactivation; management
Show Figures

Figure 1

MDPI and ACS Style

MORETTO, F.; CATHERINE, F.-X.; ESTEVE, C.; BLOT, M.; PIROTH, L. Isolated Anti-HBc: Significance and Management. J. Clin. Med. 2020, 9, 202.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop